Fig. 33
From: Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review
![Fig. 33](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13244-019-0801-z/MediaObjects/13244_2019_801_Fig33_HTML.png)
Axial CT in late arterial phase obtained (a) pretreatment: image shows an enhancing 6-cm LR-5 observation in segment VI (arrows). b 1 month post transarterial radioembolization (TARE): image shows no change. c 6 months post TARE: image shows atrophy and diffuse enhancement of segment VI, hypoenhancement at the anterior aspect of the lesion and faint posterior enhancement (arrowhead). These changes may represent treatment-specific expected enhancement pattern or residual tumor. The treated observation is categorized LR-TR Equivocal